Non-invasive Aesthetic Treatment Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 80.27 Billion |
| Market Size (2029) | USD 151.31 Billion |
| CAGR (2024 - 2029) | 13.52 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Non-invasive Aesthetic Treatment Market Analysis
The Non-invasive Aesthetic Treatment Market size is estimated at USD 80.27 billion in 2024, and is expected to reach USD 151.31 billion by 2029, growing at a CAGR of 13.52% during the forecast period (2024-2029).
The COVID-19 pandemic impacted the non-invasive aesthetic treatment market negatively, as the world went into quick lockdown to stop the spread of the infection due to the virus. The footfall of the people seeking aesthetics treatment is reduced at hospitals, clinics, and other places, which offer these services. Additionally, the scheduled procedures were either canceled or postponed, which impacted the market. For instance, as per the survey conducted in March 2020 by Hamilton Fraser Cosmetics Insurance in the United Kingdom on over 1,360 cosmetics practitioners, about 99.8% of practitioners stated that their practice had been affected by the ongoing COVID-19 pandemic. Moreover, the COVID-19 pandemic provided an opportunity to the companies to enhance their homecare non-invasive aesthetics products and services, as in the later phase of the pandemic, it was observed that there was an increase in the number of people seeking aesthetic treatments due to the work from a home scenario. which may augment the market growth in coming years.
As the digital world is moving forward with so many social media and other applications, the demand for beauty products has risen sharply in the last few years, as well as the increase in the demand for non-invasive aesthetic treatment procedures for beauty enhancement, which is the major driving factor behind the high growth rate of the market studied. Over the year, the popularity of non-invasive aesthetic treatment methods gained traction because they involve scarless and quick treatment procedures compared to other beauty enhancement procedures. For instance, as per the 2020 report of the American Society of Plastic Surgeons, the total minimally invasive cosmetic procedures conducted in the United States in 2020 was about 13,281,235, of which botulinum toxin type procedure were 4,401,536.
Other factors that may complement the growth of the non-invasive aesthetic treatment market during the forecast period are the technological advancement and launch of new products in the area, and its awareness in the old age people, which represent a fair share of the world population. For instance, in August 2020, Lumenis Ltd launched a new device for non-invasive treatment devices for personalized non-invasive radiofrequency (RF) treatments. According to the requirement of every patient, the device is called NuEra Tight.
The availability of low-cost beauty products in the market and complications and risks associated with the aesthetic treatment methods are the major restraining factors for the non-invasive aesthetic treatment market, as the other beauty products are cheap and readily available as compared to specialized non-invasive treatments, while the risks associated with the procedures create fear and misconceptions among potential users.
Non-invasive Aesthetic Treatment Market Trends
Injectable Segment is Expected to Occupy a Significant Market Share Over the Forecast Period
In terms of procedure, the injectable segment is expected to occupy a significant market share in the forecast period as compared to other procedures like skin rejuvenation, non-surgical fat removal, etc. Compared to other available options in the injectable segment, the botulinum toxin (most commonly known as Botox) market is increasing very rapidly and is the most widely used injectable in non-invasive beauty enhancement procedures, worldwide. As per a 2019 report by the International Society of Aesthetic Plastic Surgery, 6,271,488 botulinum toxin procedures were done globally, constituting 46.1% of the total non-invasive procedures.
The other factors complementing the growth of the injectables market are new R&D in the area and the launch of a new and advanced solution by the key market players in the area who are actively working toward bringing improvement in the non-invasive aesthetic treatment market. For example, in June 2021, the United States Food and Drug Administration provided its approval to Galderma's Restylane Contour for improving cheek augmentation and midface contour deficiencies. In January 2020, the Allergan facility in the Mayo town of Westport shipped the 100 millionth vial of Botox. The Westport facility is responsible for manufacturing the global supply of the anti-wrinkle injection treatment, as the company marked 30 years since the product first received approval.
North America is Expected to Dominate the Non-Invasive Aesthetic Treatment Market during the Forecast Period
North America is expected to dominate the market of non-invasive aesthetic treatment during the forecast period mainly due to the increasing demand for beauty-enhancing procedures and the availability of a handful of resources in the region. Among all, the United States is expected to be the largest market in the North American region for the market studied. According to the 2020 report of the American Society of Plastic Surgeons, Americans have a more positive opinion toward plastic surgery or non-surgical procedures than before the COVID-19 pandemic. It also reported that about 11% of the surveyed women were interested in getting either surgical or non-surgical cosmetics procedures. The number was higher in the women who already had surgery or any kind of cosmetic procedure, about 24%.
As per the 2020 report of the International Society of Aesthetic Plastic Surgery, in 2019 the United States and Mexico were two of the top 10 countries where most cosmetic surgeries and procedures (both surgical and non-surgical) were performed. As per the International Society of Aesthetic Plastic Surgery (ISAPS) Report, 2019, the total number of botulinum A procedures that were performed accounted for 287,420 constituting 46.4% of non-surgical procedures in Mexico.
The major reason was the increasing popularity of the aesthetic treatment in the region for beauty enhancement in both adults and old age populations. Additionally, the presence of few key market leaders in the region augments the growth of the market, as they promote their products via different sources and provide better services in the region. For example, in October 2020, BTL Aesthetics announced the launch of the EMSCULPT NEO for the non-invasive procedure in the removal of fat cells and treating body contouring.
Thus, the above factors are likely to contribute to the growth of the non-invasive aesthetic treatment market in the region, along with its dominance in the market.
Non-invasive Aesthetic Treatment Industry Overview
The non-invasive aesthetic treatment market is getting very competitive due to the increase in the number of companies in the area and established market players who are also bidding for the market share, for example, the acquisition of Allergan by AbbVie in 2020. Some of the key companies for the market of non-invasive aesthetic treatment are Galderma, Alma Lasers, Hologic Inc., AbbVi Inc., Merz Pharma, Lumenis, and others.
Non-invasive Aesthetic Treatment Market Leaders
-
Alma Lasers
-
Johnson and Johnson
-
Bauch Health Companies Inc.
-
Galderma SA
-
AbbVie Inc.
*Disclaimer: Major Players sorted in no particular order
Non-invasive Aesthetic Treatment Market News
- In July 2020, Solta Medical launched a new radiofrequency device for skin tightening non-invasively. The device is called the Thermage FLX system.
- In May 2020, the United States Food and Drug Administration (FDA) approved Galderma's new hyaluronic acid-based Restylane Kysse, which had application in lips augmentation and perioral rhytids.
Non-invasive Aesthetic Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Defination
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rise in Demand for Non-invasive Aesthetic Treatment Procedures
- 4.2.2 Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Availability of Other Low Cost Beauty Product
- 4.3.2 Associated Complications and Clinical Risks
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Procedures
- 5.1.1 Injectable
- 5.1.2 Skin Rejuvanation
- 5.1.3 Non-surgical Fat Removal
- 5.1.4 Sclerotherapy
- 5.1.5 Other Procedures
-
5.2 By End Users
- 5.2.1 Hospitals
- 5.2.2 Clinics
- 5.2.3 Medical Spa
-
5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Galderma SA
- 6.1.2 Alma Lasers
- 6.1.3 Hologic Inc.
- 6.1.4 AbbVie Inc. (Allergen Inc.)
- 6.1.5 Merz Pharma
- 6.1.6 Lumenis
- 6.1.7 Bausch Health Companies Inc.
- 6.1.8 Johnson & Johnson
- 6.1.9 Syneron Candela
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNon-invasive Aesthetic Treatment Industry Segmentation
As per the scope of the report, the non-invasive aesthetic treatment procedures are those which do not require cutting of skin or insertion of any instrument in the body for different beauty enhancement procedures. Non-invasive procedures are considered safe, painless, and require less recovery time than invasive treatment procedures. The global non-invasive aesthetic treatment market is segmented by procedures (injectables, skin rejuvenation, non-surgical fat removal, sclerotherapy, and other procedures), end users (hospitals, clinics, and medical spa), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).
| By Procedures | Injectable | |
| Skin Rejuvanation | ||
| Non-surgical Fat Removal | ||
| Sclerotherapy | ||
| Other Procedures | ||
| By End Users | Hospitals | |
| Clinics | ||
| Medical Spa | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia Pacific | ||
| By Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Non-invasive Aesthetic Treatment Market Research FAQs
How big is the Non-invasive Aesthetic Treatment Market?
The Non-invasive Aesthetic Treatment Market size is expected to reach USD 80.27 billion in 2024 and grow at a CAGR of 13.52% to reach USD 151.31 billion by 2029.
What is the current Non-invasive Aesthetic Treatment Market size?
In 2024, the Non-invasive Aesthetic Treatment Market size is expected to reach USD 80.27 billion.
Who are the key players in Non-invasive Aesthetic Treatment Market?
Alma Lasers, Johnson and Johnson, Bauch Health Companies Inc., Galderma SA and AbbVie Inc. are the major companies operating in the Non-invasive Aesthetic Treatment Market.
Which is the fastest growing region in Non-invasive Aesthetic Treatment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Non-invasive Aesthetic Treatment Market?
In 2024, the North America accounts for the largest market share in Non-invasive Aesthetic Treatment Market.
What years does this Non-invasive Aesthetic Treatment Market cover, and what was the market size in 2023?
In 2023, the Non-invasive Aesthetic Treatment Market size was estimated at USD 69.42 billion. The report covers the Non-invasive Aesthetic Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Non-invasive Aesthetic Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Non-invasive Aesthetic Treatment Industry Report
Statistics for the 2023 Non-invasive Aesthetic Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Non-invasive Aesthetic Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
